Want to see NBP full AI Analyst Report?
NovaBridge Biosciences (NBP) Financial Statements
NovaBridge Biosciences Financial Overview
NovaBridge Biosciences's market cap is currently $138.62M. The company's EPS TTM is $-0.57; its P/E ratio is -2.09; NovaBridge Biosciences has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Dec 23 | Mar 23 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 4.49M | $ -10.70M | $ 88.03M |
| Gross Profit | $ 0.00 | $ 0.00 | $ 4.49M | $ -10.70M | $ 41.59M |
| Operating Income | $ -13.48M | $ -375.36M | $ -511.16M | $ -366.08M | $ -2.07B |
| EBITDA | $ -12.62M | $ -368.25M | $ -339.94M | $ -356.60M | $ -2.04B |
| Net Income | $ -6.61M | $ -162.26M | $ -1.47B | $ -967.52M | $ -2.33B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 30.14M | $ 1.27B | $ 311.73M | $ 3.45B | $ 670.96M |
| Total Assets | $ 37.24M | $ 1.55B | $ 368.92M | $ 4.07B | $ 878.74M |
| Total Debt | $ 438.46K | $ 28.33M | $ 3.89M | $ 38.29M | $ 17.64M |
| Net Debt | $ -29.67M | $ -469.90M | $ -287.62M | $ -3.18B | $ -535.16M |
| Total Liabilities | $ 4.23M | $ 84.08M | $ 126.34M | $ 1.07B | $ 163.42M |
| Stockholders' Equity | $ 33.02M | $ 1.47B | $ 242.58M | $ 3.01B | $ 715.33M |
| Cash Flow | |||||
| Free Cash Flow | $ -20.60M | $ -384.77M | $ -73.02M | $ -1.15B | $ -1.00B |
| Operating Cash Flow | $ -20.60M | $ -384.29M | $ -72.85M | $ -1.10B | $ -973.09M |
| Investing Cash Flow | $ 104.97M | $ -992.42M | $ -107.63M | $ 458.38M | $ -727.21M |
| Financing Cash Flow | $ 57.73M | $ -2.44M | $ -8.25M | $ 42.36M | $ 593.92M |
Currency in CNY
